5 assets in Pancoast Syndrome

Therapeutic assets addressing Pancoast Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cis-Diamminedichloroplatinum Ii Pancoast Syndrome	National Cancer Center Hospital East	P3	B (60)
Durvalumab Pancoast Syndrome	National Cancer Center Hospital East	P3	B (60)
S-1 Pancoast Syndrome	National Cancer Center Hospital East	P3	B (60)
Carboplatin Pancoast Syndrome	Fundación GECP	P2	CCC (53)
Nivolumab Pancoast Syndrome	Fundación GECP	P2	CCC (53)